abstract |
DEVICES AND METHODS FOR TREATING MEMORY IMPAIRMENT Abstract of the Disclosure The invention is directed to the use of arecoline, physostigmine, naloxona or nicotine, as well as of some derivatives of these compounds as defined in the specification, as nootropics. From suitable devices these compounds are released e.g. transdermally or orally at a continuous controlled rate. |